BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1088 related articles for article (PubMed ID: 19000054)

  • 41. Predictors of completion axillary lymph node dissection in patients with immunohistochemical metastases to the sentinel lymph node in breast cancer.
    Pugliese MS; Karam AK; Hsu M; Stempel MM; Patil SM; Ho AY; Traina TA; Van Zee KJ; Cody HS; Morrow M; Gemignani ML
    Ann Surg Oncol; 2010 Apr; 17(4):1063-8. PubMed ID: 20033325
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Primary tumor characteristics predict sentinel lymph node macrometastasis in breast cancer.
    Tan YY; Wu CT; Fan YG; Hwang S; Ewing C; Lane K; Esserman L; Lu Y; Treseler P; Morita E; Leong SP
    Breast J; 2005; 11(5):338-43. PubMed ID: 16174155
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Sentinel lymph node biopsy is successful and accurate in male breast carcinoma.
    Flynn LW; Park J; Patil SM; Cody HS; Port ER
    J Am Coll Surg; 2008 Apr; 206(4):616-21. PubMed ID: 18387465
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Do cytokeratin-positive-only sentinel lymph nodes warrant complete axillary lymph node dissection in patients with invasive breast cancer?
    Teng S; Dupont E; McCann C; Wang J; Bolano M; Durand K; Peltz E; Bass SS; Cantor A; Ku NN; Cox CE
    Am Surg; 2000 Jun; 66(6):574-8. PubMed ID: 10888134
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Biopsy type does not influence sentinel lymph node status.
    Chagpar AB; Scoggins CR; Sahoo S; Martin RC; Carlson DJ; Laidley AL; El-Eid SE; McGlothin TQ; Noyes RD; Ley PB; Tuttle TM; McMasters KM
    Am J Surg; 2005 Oct; 190(4):551-6. PubMed ID: 16164918
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Very slight chance of other metastases in axillary nodes of breast cancer patients with a small sentinel node metastasis without extranodal tumor growth].
    van der Loo EM; Hop WC; Tervoort MA; de Graaf PW
    Ned Tijdschr Geneeskd; 2004 May; 148(19):938-43. PubMed ID: 15160561
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinical implications of occult metastases and isolated tumor cells in sentinel and non-sentinel lymph nodes in early breast cancer patients: serial step section analysis with long-term follow-up.
    Takeshita T; Tsuda H; Moriya T; Yamasaki T; Asakawa H; Ueda S; Sato K; Aida S; Tamai S; Matsubara O; Hase K; Yamamoto J
    Ann Surg Oncol; 2012 Apr; 19(4):1160-6. PubMed ID: 21989659
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The effect of sentinel node tumor burden on non-sentinel node status and recurrence rates in breast cancer.
    Fan YG; Tan YY; Wu CT; Treseler P; Lu Y; Chan CW; Hwang S; Ewing C; Esserman L; Morita E; Leong SP
    Ann Surg Oncol; 2005 Sep; 12(9):705-11. PubMed ID: 16079953
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Sentinel lymph node biopsy in breast cancer].
    Shen K; Nirmal L; Han Q; Wu J; Lu J; Zhang J; Liu G; Shao Z; Shen Z
    Zhonghua Wai Ke Za Zhi; 2002 May; 40(5):347-50. PubMed ID: 12133338
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Are 3 sentinel nodes sufficient?
    Chagpar AB; Scoggins CR; Martin RC; Carlson DJ; Laidley AL; El-Eid SE; McGlothin TQ; McMasters KM;
    Arch Surg; 2007 May; 142(5):456-9; discussion 459-60. PubMed ID: 17515487
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Predicting the status of axillary sentinel lymph nodes in 4351 patients with invasive breast carcinoma treated in a single institution.
    Viale G; Zurrida S; Maiorano E; Mazzarol G; Pruneri G; Paganelli G; Maisonneuve P; Veronesi U
    Cancer; 2005 Feb; 103(3):492-500. PubMed ID: 15612028
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Sentinel lymph node metastasis from mammary ductal carcinoma in situ with microinvasion.
    Zavagno G; Belardinelli V; Marconato R; Carcoforo P; Franchini Z; Scalco G; Burelli P; Pietrarota P; Mencarelli R; Marconato G; Nitti D
    Breast; 2007 Apr; 16(2):146-51. PubMed ID: 17046258
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Factors predicting non-sentinel lymph node involvement in sentinel node positive breast carcinoma.
    Durak MG; Akansu B; Akin MM; Sevınç AI; Koçdor MA; Saydam S; Harmancioğlu O; Ellıdokuz H; Bekış R; Canda T
    Turk Patoloji Derg; 2011; 27(3):189-95. PubMed ID: 21935867
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Immunohistochemically detected tumor cells in the sentinel lymph nodes of patients with breast carcinoma: biologic metastasis or procedural artifact?
    Moore KH; Thaler HT; Tan LK; Borgen PI; Cody HS
    Cancer; 2004 Mar; 100(5):929-34. PubMed ID: 14983487
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Significance of sentinel lymph node micrometastases in human breast cancer.
    Cox CE; Kiluk JV; Riker AI; Cox JM; Allred N; Ramos DC; Dupont EL; Vrcel V; Diaz N; Boulware D
    J Am Coll Surg; 2008 Feb; 206(2):261-8. PubMed ID: 18222378
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Risk of stage underestimation of breast cancer by sentinel lymph node biopsy method].
    Houvenaeghel G; Martino M; Jacquemier J; Moutardier V; Tallet A; Viens P; Puig B; Bardou VJ
    Bull Cancer; 2003 May; 90(5):467-73. PubMed ID: 12850770
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Predictive probability of four different breast cancer nomograms for nonsentinel axillary lymph node metastasis in positive sentinel node biopsy.
    Gur AS; Unal B; Johnson R; Ahrendt G; Bonaventura M; Gordon P; Soran A
    J Am Coll Surg; 2009 Feb; 208(2):229-35. PubMed ID: 19228534
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparison of sentinel lymph node biopsy alone and completion axillary lymph node dissection for node-positive breast cancer.
    Bilimoria KY; Bentrem DJ; Hansen NM; Bethke KP; Rademaker AW; Ko CY; Winchester DP; Winchester DJ
    J Clin Oncol; 2009 Jun; 27(18):2946-53. PubMed ID: 19364968
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Sentinel lymph node biopsy and non-sentinel node involvement in special type breast carcinomas with a good prognosis.
    Cserni G; Bianchi S; Vezzosi V; Arisio R; Bori R; Peterse JL; Sapino A; Drijkoningen M; Kulka J; Eusebi V; Foschini MP; Bellocq JP; Marin C; Thorstenson S; Amendoeira I; Reiner-Concin A; Decker T
    Eur J Cancer; 2007 Jun; 43(9):1407-14. PubMed ID: 17531465
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A Randomized clinical trial on sentinel lymph node biopsy versus axillary lymph node dissection in breast cancer: results of the Sentinella/GIVOM trial.
    Zavagno G; De Salvo GL; Scalco G; Bozza F; Barutta L; Del Bianco P; Renier M; Racano C; Carraro P; Nitti D;
    Ann Surg; 2008 Feb; 247(2):207-13. PubMed ID: 18216523
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 55.